Welcome international healthcare professionals

This site is no longer supported and will not be updated with new content. You are welcome to browse and download all content already included in the site. Please note you will have to register your email address to access the site.

You are here

Lenalidomide in combination with R-CHOP in lymphoma

Sanjeet Bagcchi

The Lancet Oncology, In Press, Corrected Proof, Available online 28 August 2014

Lenalidomide combined with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) shows activity in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), new research suggests.

DLBCL has two major subtypes: germinal centre B-cell-like (GCB) and activated B-cell-like (ABC). Although R-CHOP is considered standard-of-care therapy for patients with newly diagnosed DLBCL, treatment outcomes for patients with ABC DLBCL are poor. Lenalidomide has shown significan ...


Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Search this site

Search form